Cargando…

Antibiotic Treatment and Age Are Associated With Staphylococcus aureus Carriage Profiles During Persistence in the Airways of Cystic Fibrosis Patients

BACKGROUND: Staphylococcus aureus is one of the most isolated pathogens from the airways of cystic fibrosis (CF) patients. There is a lack of information about the clonal nature of S. aureus cultured from CF patients and their impact on disease. We hypothesized that patients would differ in their cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Westphal, Corinna, Görlich, Dennis, Kampmeier, Stefanie, Herzog, Susann, Braun, Nadja, Hitschke, Carina, Mellmann, Alexander, Peters, Georg, Kahl, Barbara C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055462/
https://www.ncbi.nlm.nih.gov/pubmed/32174894
http://dx.doi.org/10.3389/fmicb.2020.00230
_version_ 1783503371648368640
author Westphal, Corinna
Görlich, Dennis
Kampmeier, Stefanie
Herzog, Susann
Braun, Nadja
Hitschke, Carina
Mellmann, Alexander
Peters, Georg
Kahl, Barbara C.
author_facet Westphal, Corinna
Görlich, Dennis
Kampmeier, Stefanie
Herzog, Susann
Braun, Nadja
Hitschke, Carina
Mellmann, Alexander
Peters, Georg
Kahl, Barbara C.
author_sort Westphal, Corinna
collection PubMed
description BACKGROUND: Staphylococcus aureus is one of the most isolated pathogens from the airways of cystic fibrosis (CF) patients. There is a lack of information about the clonal nature of S. aureus cultured from CF patients and their impact on disease. We hypothesized that patients would differ in their clinical status depending on S. aureus clonal carriage profiles during persistence. METHODS: During a 21-months prospective observational multicenter study (Junge et al., 2016), 3893 S. aureus isolates (nose, oropharynx, and sputa) were cultured from 183 CF patients (16 German centers, 1 Austrian center) and subjected to spa-sequence typing to assess clonality. Data were associated to lung function, age, gender, and antibiotic treatment by multivariate regression analysis. RESULTS: Two hundred and sixty-five different spa-types were determined with eight prevalent spa-types (isolated from more than 10 patients): t084, t091, t008, t015, t002 t012, t364, and t056. We observed different carriage profiles of spa-types during the study period: patients being positive with a prevalent spa-type, only one, a dominant or related spa-type/s. Patients with more antibiotic cycles were more likely to be positive for only one spa-type (p = 0.005), while older patients were more likely to have related (p = 0.006), or dominant spa-types (p = 0.026). Two percent of isolates were identified as methicillin-resistant S. aureus (MRSA) and evidence of transmission of clones within centers was low. CONCLUSION: There was a significant association of antibiotic therapy and age on S. aureus carriage profiles in CF patients indicating that antibiotic therapy prevents acquisition of new clones, while during aging of patients with persisting S. aureus, dominant clones were selected and mutations in the spa-repeat region accumulated.
format Online
Article
Text
id pubmed-7055462
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-70554622020-03-13 Antibiotic Treatment and Age Are Associated With Staphylococcus aureus Carriage Profiles During Persistence in the Airways of Cystic Fibrosis Patients Westphal, Corinna Görlich, Dennis Kampmeier, Stefanie Herzog, Susann Braun, Nadja Hitschke, Carina Mellmann, Alexander Peters, Georg Kahl, Barbara C. Front Microbiol Microbiology BACKGROUND: Staphylococcus aureus is one of the most isolated pathogens from the airways of cystic fibrosis (CF) patients. There is a lack of information about the clonal nature of S. aureus cultured from CF patients and their impact on disease. We hypothesized that patients would differ in their clinical status depending on S. aureus clonal carriage profiles during persistence. METHODS: During a 21-months prospective observational multicenter study (Junge et al., 2016), 3893 S. aureus isolates (nose, oropharynx, and sputa) were cultured from 183 CF patients (16 German centers, 1 Austrian center) and subjected to spa-sequence typing to assess clonality. Data were associated to lung function, age, gender, and antibiotic treatment by multivariate regression analysis. RESULTS: Two hundred and sixty-five different spa-types were determined with eight prevalent spa-types (isolated from more than 10 patients): t084, t091, t008, t015, t002 t012, t364, and t056. We observed different carriage profiles of spa-types during the study period: patients being positive with a prevalent spa-type, only one, a dominant or related spa-type/s. Patients with more antibiotic cycles were more likely to be positive for only one spa-type (p = 0.005), while older patients were more likely to have related (p = 0.006), or dominant spa-types (p = 0.026). Two percent of isolates were identified as methicillin-resistant S. aureus (MRSA) and evidence of transmission of clones within centers was low. CONCLUSION: There was a significant association of antibiotic therapy and age on S. aureus carriage profiles in CF patients indicating that antibiotic therapy prevents acquisition of new clones, while during aging of patients with persisting S. aureus, dominant clones were selected and mutations in the spa-repeat region accumulated. Frontiers Media S.A. 2020-02-26 /pmc/articles/PMC7055462/ /pubmed/32174894 http://dx.doi.org/10.3389/fmicb.2020.00230 Text en Copyright © 2020 Westphal, Görlich, Kampmeier, Herzog, Braun, Hitschke, Staphylococcal CF Study Group, Mellmann, Peters and Kahl. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Westphal, Corinna
Görlich, Dennis
Kampmeier, Stefanie
Herzog, Susann
Braun, Nadja
Hitschke, Carina
Mellmann, Alexander
Peters, Georg
Kahl, Barbara C.
Antibiotic Treatment and Age Are Associated With Staphylococcus aureus Carriage Profiles During Persistence in the Airways of Cystic Fibrosis Patients
title Antibiotic Treatment and Age Are Associated With Staphylococcus aureus Carriage Profiles During Persistence in the Airways of Cystic Fibrosis Patients
title_full Antibiotic Treatment and Age Are Associated With Staphylococcus aureus Carriage Profiles During Persistence in the Airways of Cystic Fibrosis Patients
title_fullStr Antibiotic Treatment and Age Are Associated With Staphylococcus aureus Carriage Profiles During Persistence in the Airways of Cystic Fibrosis Patients
title_full_unstemmed Antibiotic Treatment and Age Are Associated With Staphylococcus aureus Carriage Profiles During Persistence in the Airways of Cystic Fibrosis Patients
title_short Antibiotic Treatment and Age Are Associated With Staphylococcus aureus Carriage Profiles During Persistence in the Airways of Cystic Fibrosis Patients
title_sort antibiotic treatment and age are associated with staphylococcus aureus carriage profiles during persistence in the airways of cystic fibrosis patients
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055462/
https://www.ncbi.nlm.nih.gov/pubmed/32174894
http://dx.doi.org/10.3389/fmicb.2020.00230
work_keys_str_mv AT westphalcorinna antibiotictreatmentandageareassociatedwithstaphylococcusaureuscarriageprofilesduringpersistenceintheairwaysofcysticfibrosispatients
AT gorlichdennis antibiotictreatmentandageareassociatedwithstaphylococcusaureuscarriageprofilesduringpersistenceintheairwaysofcysticfibrosispatients
AT kampmeierstefanie antibiotictreatmentandageareassociatedwithstaphylococcusaureuscarriageprofilesduringpersistenceintheairwaysofcysticfibrosispatients
AT herzogsusann antibiotictreatmentandageareassociatedwithstaphylococcusaureuscarriageprofilesduringpersistenceintheairwaysofcysticfibrosispatients
AT braunnadja antibiotictreatmentandageareassociatedwithstaphylococcusaureuscarriageprofilesduringpersistenceintheairwaysofcysticfibrosispatients
AT hitschkecarina antibiotictreatmentandageareassociatedwithstaphylococcusaureuscarriageprofilesduringpersistenceintheairwaysofcysticfibrosispatients
AT mellmannalexander antibiotictreatmentandageareassociatedwithstaphylococcusaureuscarriageprofilesduringpersistenceintheairwaysofcysticfibrosispatients
AT petersgeorg antibiotictreatmentandageareassociatedwithstaphylococcusaureuscarriageprofilesduringpersistenceintheairwaysofcysticfibrosispatients
AT kahlbarbarac antibiotictreatmentandageareassociatedwithstaphylococcusaureuscarriageprofilesduringpersistenceintheairwaysofcysticfibrosispatients
AT antibiotictreatmentandageareassociatedwithstaphylococcusaureuscarriageprofilesduringpersistenceintheairwaysofcysticfibrosispatients